| Materials engineering for immunomodulation JA Hubbell, SN Thomas, MA Swartz Nature 462 (7272), 449-460, 2009 | 632 | 2009 |
| Material design for lymph node drug delivery A Schudel, DM Francis, SN Thomas Nature Reviews Materials 4 (6), 415-428, 2019 | 379 | 2019 |
| VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics AW Lund, FV Duraes, S Hirosue, VR Raghavan, C Nembrini, SN Thomas, ... Cell reports 1 (3), 191-199, 2012 | 335 | 2012 |
| Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response SN Thomas, E Vokali, AW Lund, JA Hubbell, MA Swartz Biomaterials 35 (2), 814-824, 2014 | 312 | 2014 |
| Cancer cells in transit: the vascular interactions of tumor cells K Konstantopoulos, SN Thomas Annual review of biomedical engineering 11 (1), 177-202, 2009 | 283 | 2009 |
| Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E-and L-selectin in shear flow SN Thomas, F Zhu, RL Schnaar, CS Alves, K Konstantopoulos Journal of biological chemistry 283 (23), 15647-15655, 2008 | 230 | 2008 |
| Size-and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages SS Yu, CM Lau, SN Thomas, WG Jerome, DJ Maron, JH Dickerson, ... International journal of nanomedicine, 799-813, 2012 | 206 | 2012 |
| Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy DM Francis, MP Manspeaker, A Schudel, LF Sestito, MJ O’Melia, ... Science translational medicine 12 (563), eaay3575, 2020 | 190 | 2020 |
| Variant isoforms of CD44 are P‐and L‐selectin ligands on colon carcinoma cells WD Hanley, SL Napier, MM Burdick, RL Schnaar, R Sackstein, ... The FASEB journal 20 (2), 337-339, 2006 | 160 | 2006 |
| Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands SL Napier, ZR Healy, RL Schnaar, K Konstantopoulos Journal of biological chemistry 282 (6), 3433-3441, 2007 | 152 | 2007 |
| Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage SN Thomas, JM Rutkowski, M Pasquier, EL Kuan, K Alitalo, GJ Randolph, ... The Journal of Immunology 189 (5), 2181-2190, 2012 | 147 | 2012 |
| Engineering complement activation on polypropylene sulfide vaccine nanoparticles SN Thomas, AJ van der Vlies, CP O’Neil, ST Reddy, SY Shann, ... Biomaterials 32 (8), 2194-2203, 2011 | 138 | 2011 |
| The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion CS Alves, MM Burdick, SN Thomas, P Pawar, K Konstantopoulos American Journal of Physiology-Cell Physiology 294 (4), C907-C916, 2008 | 131 | 2008 |
| Programmable multistage drug delivery to lymph nodes A Schudel, AP Chapman, MK Yau, CJ Higginson, DM Francis, ... Nature nanotechnology 15 (6), 491-499, 2020 | 120 | 2020 |
| Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery SN Thomas, A Schudel Current opinion in chemical engineering 7, 65-74, 2015 | 106 | 2015 |
| Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells SN Thomas, RL Schnaar, K Konstantopoulos American journal of physiology-Cell physiology 296 (3), C505-C513, 2009 | 105 | 2009 |
| Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy DM Francis, SN Thomas Advanced drug delivery reviews 114, 33-42, 2017 | 100 | 2017 |
| Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12–13, and 17q21–23 and novel evidence at 3p24, 10q23–24, 13q32, and 18q22–23 RM Cantor, J Yuan, S Napier, N Kono, JM Grossman, BH Hahn, BP Tsao Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 99 | 2004 |
| Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy J Kim, DM Francis, LF Sestito, PA Archer, MP Manspeaker, MJ O’Melia, ... Nature Communications 13 (1), 1479, 2022 | 89 | 2022 |
| Implications of lymphatic transport to lymph nodes in immunity and immunotherapy SN Thomas, NA Rohner, EE Edwards Annual review of biomedical engineering 18 (1), 207-233, 2016 | 87 | 2016 |
